HCC827 cell |
Proliferation assay |
|
|
|
Antiproliferative activity against human HCC827 cells after 96 hrs by MTS assay, IC50=8 nM |
20550212 |
NCI-H1563 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay. IC50=9.76031 μM |
SANGER |
NCI-H1573 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1573 cell growth in a cell viability assay. IC50=0.7363 μM |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay. IC50=29.3145 μM |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay. IC50=0.44182 μM |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay. IC50=14.2087 μM |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay. IC50=0.60299 μM |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay. IC50=0.1028 μM |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay. IC50=25.597 μM |
SANGER |
NCI-H1975 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1975 cell growth in a cell viability assay. IC50=0.61728 μM |
SANGER |
NCI-H1666 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1666 cell growth in a cell viability assay. IC50=1.80948 μM |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay. IC50=3.61216 μM |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay. IC50=0.51926 μM |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay. IC50=3.84181 μM |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay. IC50=49.9682 μM |
SANGER |
NCI-H2029 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2029 cell growth in a cell viability assay. IC50=43.5581 μM |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay. IC50=0.03728 μM |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay. IC50=49.7785 μM |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay. IC50=14.6448 μM |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay. IC50=21.8963 μM |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay. IC50=0.0609 μM |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay. IC50=3.59841 μM |
SANGER |
NCI-H2291 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2291 cell growth in a cell viability assay. IC50=5.98943 μM |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay. IC50=0.5321 μM |
SANGER |
NCI-H460 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay. IC50=46.523 μM |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay. IC50=16.9694 μM |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay. IC50=37.4196 μM |
SANGER |
NCI-H630 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H630 cell growth in a cell viability assay. IC50=1.45582 μM |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay. IC50=17.557 μM |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay. IC50=0.21451 μM |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay. IC50=11.2418 μM |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay. IC50=5.42472 μM |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay. IC50=17.1974 μM |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay. IC50=24.8861 μM |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay. IC50=34.7278 μM |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay. IC50=0.05325 μM |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay. IC50=3.69735 μM |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay. IC50=7.72808 μM |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay. IC50=1.239 μM |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay. IC50=3.18744 μM |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay. IC50=0.07823 μM |
SANGER |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay. IC50=5.54537 μM |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay. IC50=12.9234 μM |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay. IC50=1.54006 μM |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay. IC50=0.08025 μM |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay. IC50=34.5703 μM |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay. IC50=0.02773 μM |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay. IC50=9.60946 μM |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay. IC50=9.34375 μM |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay. IC50=41.8725 μM |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay. IC50=8.33631 μM |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay. IC50=0.2046 μM |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay. IC50=34.3471 μM |
SANGER |
NY |
Growth inhibition assay |
|
|
|
Inhibition of human NY cell growth in a cell viability assay. IC50=3.53655 μM |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay. IC50=3.50026 μM |
SANGER |
OC-314 |
Growth inhibition assay |
|
|
|
Inhibition of human OC-314 cell growth in a cell viability assay. IC50=15.4714 μM |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay. IC50=32.6602 μM |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay. IC50=8.95481 μM |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay. IC50=3.76187 μM |
SANGER |
OE33 |
Growth inhibition assay |
|
|
|
Inhibition of human OE33 cell growth in a cell viability assay. IC50=13.786 μM |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay. IC50=7.16405 μM |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay. IC50=9.0219 μM |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay. IC50=41.4709 μM |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay. IC50=2.67167 μM |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay. IC50=10.8835 μM |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay. IC50=13.1593 μM |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay. IC50=25.4785 μM |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay. IC50=37.4862 μM |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay. IC50=31.4006 μM |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay. IC50=12.0369 μM |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PA-1 cell growth in a cell viability assay. IC50=49.8335 μM |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-14 cell growth in a cell viability assay. IC50=0.05668 μM |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay. IC50=2.16631 μM |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay. IC50=1.16416 μM |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay. IC50=8.1042 μM |
SANGER |
RD |
Growth inhibition assay |
|
|
|
Inhibition of human RD cell growth in a cell viability assay. IC50=29.5233 μM |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay. IC50=16.7105 μM |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay. IC50=17.5508 μM |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay. IC50=18.0559 μM |
SANGER |
RH-18 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-18 cell growth in a cell viability assay. IC50=18.0035 μM |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay. IC50=32.1604 μM |
SANGER |
RKO |
Growth inhibition assay |
|
|
|
Inhibition of human RKO cell growth in a cell viability assay. IC50=14.5075 μM |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay. IC50=3.0759 μM |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay. IC50=14.5472 μM |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay. IC50=4.11631 μM |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay. IC50=12.1725 μM |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
|
Inhibition of human RXF393 cell growth in a cell viability assay. IC50=36.3785 μM |
SANGER |
NOS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay. IC50=11.711 μM |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay. IC50=14.0202 μM |
SANGER |
S-117 |
Growth inhibition assay |
|
|
|
Inhibition of human S-117 cell growth in a cell viability assay. IC50=36.3008 μM |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay. IC50=0.84171 μM |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay. IC50=0.18959 μM |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay. IC50=1.39451 μM |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay. IC50=8.44059 μM |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay. IC50=0.38373 μM |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay. IC50=37.7838 μM |
SANGER |
SCH |
Growth inhibition assay |
|
|
|
Inhibition of human SCH cell growth in a cell viability assay. IC50=18.6456 μM |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay. IC50=7.94578 μM |
SANGER |
SF126 |
Growth inhibition assay |
|
|
|
Inhibition of human SF126 cell growth in a cell viability assay. IC50=23.6924 μM |
SANGER |
SF295 |
Growth inhibition assay |
|
|
|
Inhibition of human SF295 cell growth in a cell viability assay. IC50=26.0425 μM |
SANGER |
OE19 |
Growth inhibition assay |
|
|
|
Inhibition of human OE19 cell growth in a cell viability assay. IC50=1.71512 μM |
SANGER |
SF539 |
Growth inhibition assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay. IC50=9.23562 μM |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay. IC50=32.1858 μM |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay. IC50=29.6182 μM |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay. IC50=2.08169 μM |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay. IC50=30.6326 μM |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay. IC50=27.0176 μM |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay. IC50=15.8861 μM |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay. IC50=40.6568 μM |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay. IC50=13.7135 μM |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay. IC50=11.2366 μM |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay. IC50=35.8752 μM |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay. IC50=14.6247 μM |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay. IC50=16.4787 μM |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay. IC50=1.11487 μM |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-3 cell growth in a cell viability assay. IC50=19.9604 μM |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay. IC50=1.17513 μM |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay. IC50=28.6885 μM |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay. IC50=8.71329 μM |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay. IC50=13.06 μM |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay. IC50=35.4369 μM |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay. IC50=13.1083 μM |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay. IC50=2.52938 μM |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay. IC50=3.52237 μM |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay. IC50=40.4553 μM |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay. IC50=3.65826 μM |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
|
Inhibition of human RMG-I cell growth in a cell viability assay. IC50=7.39296 μM |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay. IC50=2.68616 μM |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay. IC50=11.5885 μM |
SANGER |
SW1116 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1116 cell growth in a cell viability assay. IC50=1.01287 μM |
SANGER |
SW13 |
Growth inhibition assay |
|
|
|
Inhibition of human SW13 cell growth in a cell viability assay. IC50=0.16216 μM |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1463 cell growth in a cell viability assay. IC50=15.0485 μM |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay. IC50=27.7562 μM |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay. IC50=22.8616 μM |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1710 cell growth in a cell viability assay. IC50=8.18515 μM |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay. IC50=35.7645 μM |
SANGER |
SW626 |
Growth inhibition assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay. IC50=11.5755 μM |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1990 cell growth in a cell viability assay. IC50=16.1755 μM |
SANGER |
SW756 |
Growth inhibition assay |
|
|
|
Inhibition of human SW756 cell growth in a cell viability assay. IC50=6.91176 μM |
SANGER |
SW48 |
Growth inhibition assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay. IC50=1.25432 μM |
SANGER |
SW620 |
Growth inhibition assay |
|
|
|
Inhibition of human SW620 cell growth in a cell viability assay. IC50=5.24964 μM |
SANGER |
SAS |
Growth inhibition assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay. IC50=0.48398 μM |
SANGER |
SW837 |
Growth inhibition assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay. IC50=12.9028 μM |
SANGER |
SW872 |
Growth inhibition assay |
|
|
|
Inhibition of human SW872 cell growth in a cell viability assay. IC50=42.6331 μM |
SANGER |
SW900 |
Growth inhibition assay |
|
|
|
Inhibition of human SW900 cell growth in a cell viability assay. IC50=7.82121 μM |
SANGER |
SW948 |
Growth inhibition assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay. IC50=46.4462 μM |
SANGER |
SiHa |
Growth inhibition assay |
|
|
|
Inhibition of human SiHa cell growth in a cell viability assay. IC50=23.9327 μM |
SANGER |
SW962 |
Growth inhibition assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay. IC50=5.62032 μM |
SANGER |
T-24 |
Growth inhibition assay |
|
|
|
Inhibition of human T-24 cell growth in a cell viability assay. IC50=34.0205 μM |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay. IC50=19.1162 μM |
SANGER |
T47D |
Growth inhibition assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay. IC50=3.62217 μM |
SANGER |
T98G |
Growth inhibition assay |
|
|
|
Inhibition of human T98G cell growth in a cell viability assay. IC50=27.5846 μM |
SANGER |
T84 |
Growth inhibition assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay. IC50=11.3907 μM |
SANGER |
SF268 |
Growth inhibition assay |
|
|
|
Inhibition of human SF268 cell growth in a cell viability assay. IC50=29.5932 μM |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay. IC50=34.1754 μM |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-1 cell growth in a cell viability assay. IC50=1.81475 μM |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay. IC50=0.31923 μM |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay. IC50=30.2108 μM |
SANGER |
5637 |
Growth inhibition assay |
|
|
|
Inhibition of human 5637 cell growth in a cell viability assay. IC50=1.0151 μM |
SANGER |
647-V |
Growth inhibition assay |
|
|
|
Inhibition of human 647-V cell growth in a cell viability assay. IC50=3.98452 μM |
SANGER |
639-V |
Growth inhibition assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay. IC50=31.5243 μM |
SANGER |
769-P |
Growth inhibition assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay. IC50=2.29037 μM |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay. IC50=36.9483 μM |
SANGER |
8305C |
Growth inhibition assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay. IC50=3.75911 μM |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay. IC50=32.6527 μM |
SANGER |
8505C |
Growth inhibition assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay. IC50=13.2067 μM |
SANGER |
A204 |
Growth inhibition assay |
|
|
|
Inhibition of human A204 cell growth in a cell viability assay. IC50=32.5069 μM |
SANGER |
A101D |
Growth inhibition assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay. IC50=49.9425 μM |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay. IC50=19.3363 μM |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay. IC50=21.8275 μM |
SANGER |
A2780 |
Growth inhibition assay |
|
|
|
Inhibition of human A2780 cell growth in a cell viability assay. IC50=2.06294 μM |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay. IC50=23.1003 μM |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay. IC50=22.1419 μM |
SANGER |
A431 |
Growth inhibition assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay. IC50=0.48233 μM |
SANGER |
A388 |
Growth inhibition assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay. IC50=0.36857 μM |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay. IC50=28.433 μM |
SANGER |
A549 |
Growth inhibition assay |
|
|
|
Inhibition of human A549 cell growth in a cell viability assay. IC50=6.12553 μM |
SANGER |
A673 |
Growth inhibition assay |
|
|
|
Inhibition of human A673 cell growth in a cell viability assay. IC50=41.5157 μM |
SANGER |
ACN |
Growth inhibition assay |
|
|
|
Inhibition of human ACN cell growth in a cell viability assay. IC50=0.55094 μM |
SANGER |
A704 |
Growth inhibition assay |
|
|
|
Inhibition of human A704 cell growth in a cell viability assay. IC50=18.4753 μM |
SANGER |
SN12C |
Growth inhibition assay |
|
|
|
Inhibition of human SN12C cell growth in a cell viability assay. IC50=2.91964 μM |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay. IC50=11.2512 μM |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay. IC50=34.3693 μM |
SANGER |
ACHN |
Growth inhibition assay |
|
|
|
Inhibition of human ACHN cell growth in a cell viability assay. IC50=0.31994 μM |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay. IC50=28.4395 μM |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay. IC50=33.1416 μM |
SANGER |
AU565 |
Growth inhibition assay |
|
|
|
Inhibition of human AU565 cell growth in a cell viability assay. IC50=0.08504 μM |
SANGER |
BALL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BALL-1 cell growth in a cell viability assay. IC50=9.21907 μM |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay. IC50=0.34593 μM |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay. IC50=43.2356 μM |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay. IC50=4.12147 μM |
SANGER |
BHY |
Growth inhibition assay |
|
|
|
Inhibition of human BHY cell growth in a cell viability assay. IC50=0.28655 μM |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
|
Inhibition of human BCPAP cell growth in a cell viability assay. IC50=27.137 μM |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay. IC50=29.2706 μM |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
|
Inhibition of human BE-13 cell growth in a cell viability assay. IC50=7.98112 μM |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay. IC50=14.241 μM |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1573 cell growth in a cell viability assay. IC50=11.7294 μM |
SANGER |
SW684 |
Growth inhibition assay |
|
|
|
Inhibition of human SW684 cell growth in a cell viability assay. IC50=19.1326 μM |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay. IC50=0.05988 μM |
SANGER |
SW780 |
Growth inhibition assay |
|
|
|
Inhibition of human SW780 cell growth in a cell viability assay. IC50=25.3264 μM |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay. IC50=0.04986 μM |
SANGER |
SW954 |
Growth inhibition assay |
|
|
|
Inhibition of human SW954 cell growth in a cell viability assay. IC50=1.20214 μM |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay. IC50=14.764 μM |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay. IC50=0.17596 μM |
SANGER |
SW982 |
Growth inhibition assay |
|
|
|
Inhibition of human SW982 cell growth in a cell viability assay. IC50=18.2671 μM |
SANGER |
Becker |
Growth inhibition assay |
|
|
|
Inhibition of human Becker cell growth in a cell viability assay. IC50=20.7201 μM |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay. IC50=10.0973 μM |
SANGER |
C8166 |
Growth inhibition assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay. IC50=33.8854 μM |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
|
Inhibition of human C-33-A cell growth in a cell viability assay. IC50=0.81297 μM |
SANGER |
C3A |
Growth inhibition assay |
|
|
|
Inhibition of human C3A cell growth in a cell viability assay. IC50=30.2927 μM |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay. IC50=1.78211 μM |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay. IC50=28.6418 μM |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay. IC50=15.1447 μM |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay. IC50=1.88945 μM |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay. IC50=0.17636 μM |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay. IC50=31.5667 μM |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay. IC50=0.11792 μM |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay. IC50=0.61621 μM |
SANGER |
697 |
Growth inhibition assay |
|
|
|
Inhibition of human 697 cell growth in a cell viability assay. IC50=28.6331 μM |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay. IC50=9.87383 μM |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay. IC50=43.4028 μM |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay. IC50=10.9391 μM |
SANGER |
786-0 |
Growth inhibition assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay. IC50=3.06408 μM |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay. IC50=26.7752 μM |
SANGER |
A172 |
Growth inhibition assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay. IC50=12.0798 μM |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-5 cell growth in a cell viability assay. IC50=5.4085 μM |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay. IC50=0.40246 μM |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay. IC50=3.84382 μM |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay. IC50=1.6823 μM |
SANGER |
A2058 |
Growth inhibition assay |
|
|
|
Inhibition of human A2058 cell growth in a cell viability assay. IC50=15.0409 μM |
SANGER |
TI-73 |
Growth inhibition assay |
|
|
|
Inhibition of human TI-73 cell growth in a cell viability assay. IC50=0.14715 μM |
SANGER |
A427 |
Growth inhibition assay |
|
|
|
Inhibition of human A427 cell growth in a cell viability assay. IC50=37.9107 μM |
SANGER |
TK10 |
Growth inhibition assay |
|
|
|
Inhibition of human TK10 cell growth in a cell viability assay. IC50=0.26738 μM |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay. IC50=30.1238 μM |
SANGER |
A498 |
Growth inhibition assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay. IC50=0.40674 μM |
SANGER |
AGS |
Growth inhibition assay |
|
|
|
Inhibition of human AGS cell growth in a cell viability assay. IC50=0.83648 μM |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay. IC50=17.5307 μM |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay. IC50=36.8847 μM |
SANGER |
U-266 |
Growth inhibition assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay. IC50=16.2299 μM |
SANGER |
U031 |
Growth inhibition assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay. IC50=5.25424 μM |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay. IC50=41.7369 μM |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay. IC50=4.10481 μM |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay. IC50=19.6471 μM |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay. IC50=0.11885 μM |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay. IC50=0.16576 μM |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay. IC50=9.9503 μM |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay. IC50=4.86819 μM |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay. IC50=26.4514 μM |
SANGER |
BEN |
Growth inhibition assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay. IC50=27.8517 μM |
SANGER |
WM-115 |
Growth inhibition assay |
|
|
|
Inhibition of human WM-115 cell growth in a cell viability assay. IC50=11.7588 μM |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay. IC50=9.06799 μM |
SANGER |
YAPC |
Growth inhibition assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay. IC50=11.9259 μM |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-20 cell growth in a cell viability assay. IC50=3.69795 μM |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay. IC50=1.05419 μM |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay. IC50=30.5181 μM |
SANGER |
no-10 |
Growth inhibition assay |
|
|
|
Inhibition of human no-10 cell growth in a cell viability assay. IC50=16.6343 μM |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay. IC50=9.28128 μM |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay. IC50=46.7701 μM |
SANGER |
BT-549 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-549 cell growth in a cell viability assay. IC50=6.66889 μM |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay. IC50=25.967 μM |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay. IC50=42.4955 μM |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay. IC50=22.3222 μM |
SANGER |
C32 |
Growth inhibition assay |
|
|
|
Inhibition of human C32 cell growth in a cell viability assay. IC50=9.33064 μM |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay. IC50=18.746 μM |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay. IC50=0.20184 μM |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay. IC50=0.80834 μM |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay. IC50=44.339 μM |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay. IC50=16.9477 μM |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-10 cell growth in a cell viability assay. IC50=2.68078 μM |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay. IC50=20.66 μM |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay. IC50=25.2732 μM |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-12 cell growth in a cell viability assay. IC50=1.80414 μM |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay. IC50=24.1767 μM |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay. IC50=15.1579 μM |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay. IC50=0.21084 μM |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay. IC50=0.64113 μM |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-8 cell growth in a cell viability assay. IC50=1.91377 μM |
SANGER |
TGBC11TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC11TKB cell growth in a cell viability assay. IC50=47.1777 μM |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay. IC50=17.0343 μM |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay. IC50=15.4688 μM |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay. IC50=4.8488 μM |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay. IC50=2.28281 μM |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay. IC50=0.64392 μM |
SANGER |
CW-2 |
Growth inhibition assay |
|
|
|
Inhibition of human CW-2 cell growth in a cell viability assay. IC50=0.46914 μM |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay. IC50=7.64259 μM |
SANGER |
U251 |
Growth inhibition assay |
|
|
|
Inhibition of human U251 cell growth in a cell viability assay. IC50=40.4054 μM |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay. IC50=0.08353 μM |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay. IC50=0.81434 μM |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay. IC50=3.46875 μM |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay. IC50=11.2368 μM |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay. IC50=32.007 μM |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay. IC50=35.4648 μM |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-263MG cell growth in a cell viability assay. IC50=33.8378 μM |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay. IC50=8.01697 μM |
SANGER |
D-336MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-336MG cell growth in a cell viability assay. IC50=30.2892 μM |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-392MG cell growth in a cell viability assay. IC50=35.0565 μM |
SANGER |
D-566MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-566MG cell growth in a cell viability assay. IC50=29.9393 μM |
SANGER |
D-423MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-423MG cell growth in a cell viability assay. IC50=5.61705 μM |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay. IC50=13.0633 μM |
SANGER |
D-502MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay. IC50=8.29282 μM |
SANGER |
ZR-75-30 |
Growth inhibition assay |
|
|
|
Inhibition of human ZR-75-30 cell growth in a cell viability assay. IC50=0.09545 μM |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay. IC50=1.01064 μM |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay. IC50=32.5322 μM |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay. IC50=6.92012 μM |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
|
Inhibition of human DK-MG cell growth in a cell viability assay. IC50=30.5456 μM |
SANGER |
no-11 |
Growth inhibition assay |
|
|
|
Inhibition of human no-11 cell growth in a cell viability assay. IC50=3.53564 μM |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay. IC50=40.8374 μM |
SANGER |
DMS-79 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-79 cell growth in a cell viability assay. IC50=40.5889 μM |
SANGER |
DOK |
Growth inhibition assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay. IC50=0.03194 μM |
SANGER |
CFPAC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CFPAC-1 cell growth in a cell viability assay. IC50=1.42493 μM |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
|
Inhibition of human DSH1 cell growth in a cell viability assay. IC50=0.03314 μM |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-145 cell growth in a cell viability assay. IC50=0.44833 μM |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay. IC50=0.01839 μM |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay. IC50=1.40121 μM |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay. IC50=0.32219 μM |
SANGER |
Daoy |
Growth inhibition assay |
|
|
|
Inhibition of human Daoy cell growth in a cell viability assay. IC50=24.126 μM |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay. IC50=1.70152 μM |
SANGER |
ECC10 |
Growth inhibition assay |
|
|
|
Inhibition of human ECC10 cell growth in a cell viability assay. IC50=1.55369 μM |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
|
Inhibition of human EC-GI-10 cell growth in a cell viability assay. IC50=0.05912 μM |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay. IC50=37.7967 μM |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay. IC50=35.388 μM |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay. IC50=11.1045 μM |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay. IC50=0.05182 μM |
SANGER |
EKVX |
Growth inhibition assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay. IC50=1.01064 μM |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay. IC50=28.5928 μM |
SANGER |
EPLC-272H |
Growth inhibition assay |
|
|
|
Inhibition of human EPLC-272H cell growth in a cell viability assay. IC50=4.41533 μM |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay. IC50=7.41446 μM |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay. IC50=8.80976 μM |
SANGER |
ES3 |
Growth inhibition assay |
|
|
|
Inhibition of human ES3 cell growth in a cell viability assay. IC50=16.9134 μM |
SANGER |
ES8 |
Growth inhibition assay |
|
|
|
Inhibition of human ES8 cell growth in a cell viability assay. IC50=17.6087 μM |
SANGER |
ES4 |
Growth inhibition assay |
|
|
|
Inhibition of human ES4 cell growth in a cell viability assay. IC50=0.97836 μM |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay. IC50=1.37456 μM |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-1 cell growth in a cell viability assay. IC50=45.9689 μM |
SANGER |
ES5 |
Growth inhibition assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay. IC50=4.83723 μM |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-11 cell growth in a cell viability assay. IC50=9.17653 μM |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-13 cell growth in a cell viability assay. IC50=14.0352 μM |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay. IC50=0.68698 μM |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay. IC50=1.07883 μM |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-24 cell growth in a cell viability assay. IC50=21.3945 μM |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay. IC50=30.2963 μM |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay. IC50=11.1407 μM |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay. IC50=0.26892 μM |
SANGER |
FADU |
Growth inhibition assay |
|
|
|
Inhibition of human FADU cell growth in a cell viability assay. IC50=0.54404 μM |
SANGER |
G-401 |
Growth inhibition assay |
|
|
|
Inhibition of human G-401 cell growth in a cell viability assay. IC50=1.67413 μM |
SANGER |
GAK |
Growth inhibition assay |
|
|
|
Inhibition of human GAK cell growth in a cell viability assay. IC50=25.2963 μM |
SANGER |
GAMG |
Growth inhibition assay |
|
|
|
Inhibition of human GAMG cell growth in a cell viability assay. IC50=3.91314 μM |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay. IC50=2.03517 μM |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay. IC50=25.4068 μM |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay. IC50=31.0571 μM |
SANGER |
GOTO |
Growth inhibition assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay. IC50=31.8506 μM |
SANGER |
GCIY |
Growth inhibition assay |
|
|
|
Inhibition of human GCIY cell growth in a cell viability assay. IC50=1.08104 μM |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay. IC50=8.67964 μM |
SANGER |
GP5d |
Growth inhibition assay |
|
|
|
Inhibition of human GP5d cell growth in a cell viability assay. IC50=6.97394 μM |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay. IC50=18.0088 μM |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay. IC50=28.6696 μM |
SANGER |
DB |
Growth inhibition assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay. IC50=7.61005 μM |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HC-1 cell growth in a cell viability assay. IC50=5.51839 μM |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay. IC50=8.5191 μM |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay. IC50=20.6734 μM |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay. IC50=0.36408 μM |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay. IC50=14.9338 μM |
SANGER |
DEL |
Growth inhibition assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay. IC50=10.3946 μM |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay. IC50=20.5463 μM |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay. IC50=12.7564 μM |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC38 cell growth in a cell viability assay. IC50=42.9618 μM |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay. IC50=11.0754 μM |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay. IC50=0.009869 μM |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay. IC50=9.21558 μM |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-T cell growth in a cell viability assay. IC50=0.88428 μM |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay. IC50=4.86611 μM |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay. IC50=4.41007 μM |
SANGER |
HEL |
Growth inhibition assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay. IC50=7.71203 μM |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay. IC50=22.7441 μM |
SANGER |
HLE |
Growth inhibition assay |
|
|
|
Inhibition of human HLE cell growth in a cell viability assay. IC50=0.35046 μM |
SANGER |
HH |
Growth inhibition assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay. IC50=16.5162 μM |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay. IC50=48.786 μM |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay. IC50=0.27853 μM |
SANGER |
HN |
Growth inhibition assay |
|
|
|
Inhibition of human HN cell growth in a cell viability assay. IC50=0.13077 μM |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay. IC50=0.00572 μM |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay. IC50=14.8576 μM |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay. IC50=26.1226 μM |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay. IC50=41.6709 μM |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay. IC50=0.16837 μM |
SANGER |
ES1 |
Growth inhibition assay |
|
|
|
Inhibition of human ES1 cell growth in a cell viability assay. IC50=19.9213 μM |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay. IC50=0.21198 μM |
SANGER |
HSC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-4 cell growth in a cell viability assay. IC50=0.01748 μM |
SANGER |
ES7 |
Growth inhibition assay |
|
|
|
Inhibition of human ES7 cell growth in a cell viability assay. IC50=19.6292 μM |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay. IC50=27.4032 μM |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay. IC50=18.5206 μM |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-29 cell growth in a cell viability assay. IC50=3.07309 μM |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay. IC50=1.28753 μM |
SANGER |
HT55 |
Growth inhibition assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay. IC50=2.5738 μM |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-16 cell growth in a cell viability assay. IC50=27.2947 μM |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay. IC50=27.2561 μM |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay. IC50=1.01513 μM |
SANGER |
EW-22 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-22 cell growth in a cell viability assay. IC50=41.8697 μM |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay. IC50=45.0294 μM |
SANGER |
G-361 |
Growth inhibition assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay. IC50=26.1027 μM |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay. IC50=28.4028 μM |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay. IC50=5.24043 μM |
SANGER |
HuO9 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO9 cell growth in a cell viability assay. IC50=11.8774 μM |
SANGER |
G-402 |
Growth inhibition assay |
|
|
|
Inhibition of human G-402 cell growth in a cell viability assay. IC50=35.9867 μM |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay. IC50=0.25952 μM |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay. IC50=16.6576 μM |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay. IC50=0.6976 μM |
SANGER |
GCT |
Growth inhibition assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay. IC50=20.3026 μM |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay. IC50=11.456 μM |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GI-1 cell growth in a cell viability assay. IC50=22.7658 μM |
SANGER |
IST-MES1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay. IC50=18.4428 μM |
SANGER |
J82 |
Growth inhibition assay |
|
|
|
Inhibition of human J82 cell growth in a cell viability assay. IC50=15.057 μM |
SANGER |
JAR |
Growth inhibition assay |
|
|
|
Inhibition of human JAR cell growth in a cell viability assay. IC50=19.299 μM |
SANGER |
H-EMC-SS |
Growth inhibition assay |
|
|
|
Inhibition of human H-EMC-SS cell growth in a cell viability assay. IC50=32.9678 μM |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay. IC50=22.378 μM |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay. IC50=0.88299 μM |
SANGER |
H9 |
Growth inhibition assay |
|
|
|
Inhibition of human H9 cell growth in a cell viability assay. IC50=0.07132 μM |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay. IC50=20.3422 μM |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay. IC50=7.89599 μM |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay. IC50=23.1414 μM |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay. IC50=2.58297 μM |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay. IC50=0.01671 μM |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay. IC50=25.7315 μM |
SANGER |
KASUMI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KASUMI-1 cell growth in a cell viability assay. IC50=0.00911 μM |
SANGER |
KGN |
Growth inhibition assay |
|
|
|
Inhibition of human KGN cell growth in a cell viability assay. IC50=32.633 μM |
SANGER |
KLE |
Growth inhibition assay |
|
|
|
Inhibition of human KLE cell growth in a cell viability assay. IC50=4.40819 μM |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay. IC50=0.69666 μM |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay. IC50=34.1779 μM |
SANGER |
KM12 |
Growth inhibition assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay. IC50=22.356 μM |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay. IC50=5.52615 μM |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay. IC50=35.5826 μM |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay. IC50=19.2242 μM |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay. IC50=0.57661 μM |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay. IC50=3.5895 μM |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
|
Inhibition of human KP-4 cell growth in a cell viability assay. IC50=42.8832 μM |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay. IC50=19.5468 μM |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay. IC50=31.5873 μM |
SANGER |
KP-N-YN |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YN cell growth in a cell viability assay. IC50=37.6195 μM |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay. IC50=40.6768 μM |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay. IC50=0.77464 μM |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay. IC50=11.6764 μM |
SANGER |
HOS |
Growth inhibition assay |
|
|
|
Inhibition of human HOS cell growth in a cell viability assay. IC50=39.6273 μM |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay. IC50=7.94811 μM |
SANGER |
KY821 |
Growth inhibition assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay. IC50=0.0206 μM |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay. IC50=2.02732 μM |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay. IC50=0.0833 μM |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay. IC50=42.1782 μM |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay. IC50=0.05978 μM |
SANGER |
HT |
Growth inhibition assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay. IC50=40.6639 μM |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay. IC50=0.39089 μM |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay. IC50=4.52669 μM |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay. IC50=5.20839 μM |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay. IC50=30.5114 μM |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay. IC50=41.0569 μM |
SANGER |
L-363 |
Growth inhibition assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay. IC50=16.4577 μM |
SANGER |
L-428 |
Growth inhibition assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay. IC50=24.5791 μM |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay. IC50=4.1702 μM |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay. IC50=10.6034 μM |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay. IC50=2.74888 μM |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay. IC50=28.8874 μM |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay. IC50=49.8723 μM |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay. IC50=7.76771 μM |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay. IC50=35.1658 μM |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay. IC50=26.6591 μM |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay. IC50=36.7803 μM |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay. IC50=21.2729 μM |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay. IC50=4.53686 μM |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
|
Inhibition of human LN-405 cell growth in a cell viability assay. IC50=22.5913 μM |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay. IC50=13.7639 μM |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay. IC50=6.869 μM |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay. IC50=6.20706 μM |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-123 cell growth in a cell viability assay. IC50=3.74284 μM |
SANGER |
K5 |
Growth inhibition assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay. IC50=1.58357 μM |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay. IC50=5.79441 μM |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay. IC50=21.1026 μM |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay. IC50=24.1928 μM |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay. IC50=5.60944 μM |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay. IC50=0.12633 μM |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-139 cell growth in a cell viability assay. IC50=0.3051 μM |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay. IC50=37.5731 μM |
SANGER |
LXF-289 |
Growth inhibition assay |
|
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay. IC50=2.63565 μM |
SANGER |
M14 |
Growth inhibition assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay. IC50=44.1332 μM |
SANGER |
KNS-62 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-62 cell growth in a cell viability assay. IC50=3.94731 μM |
SANGER |
LoVo |
Growth inhibition assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay. IC50=2.10797 μM |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay. IC50=3.83451 μM |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay. IC50=11.6728 μM |
SANGER |
MC116 |
Growth inhibition assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay. IC50=3.95489 μM |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay. IC50=0.03416 μM |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay. IC50=16.4723 μM |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay. IC50=0.72662 μM |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay. IC50=4.50889 μM |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay. IC50=2.21828 μM |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay. IC50=11.9515 μM |
SANGER |
KU812 |
Growth inhibition assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay. IC50=0.15456 μM |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
|
Inhibition of human ME-180 cell growth in a cell viability assay. IC50=1.61096 μM |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay. IC50=4.99403 μM |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay. IC50=1.65672 μM |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay. IC50=30.1423 μM |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay. IC50=16.0488 μM |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay. IC50=37.3371 μM |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay. IC50=19.8748 μM |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay. IC50=16.3965 μM |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
|
Inhibition of human MG-63 cell growth in a cell viability assay. IC50=5.48762 μM |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay. IC50=16.0839 μM |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay. IC50=40.0112 μM |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN1 cell growth in a cell viability assay. IC50=3.47108 μM |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay. IC50=28.7959 μM |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay. IC50=32.7838 μM |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay. IC50=0.24802 μM |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay. IC50=21.1551 μM |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay. IC50=19.2607 μM |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN7 cell growth in a cell viability assay. IC50=2.35335 μM |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay. IC50=0.10884 μM |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay. IC50=38.6039 μM |
SANGER |
MOLT-13 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-13 cell growth in a cell viability assay. IC50=0.23975 μM |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay. IC50=45.9482 μM |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay. IC50=17.8935 μM |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay. IC50=7.02135 μM |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay. IC50=30.393 μM |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay. IC50=16.8403 μM |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay. IC50=22.8661 μM |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay. IC50=34.6487 μM |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay. IC50=15.4248 μM |
SANGER |
Mewo |
Growth inhibition assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay. IC50=34.1349 μM |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay. IC50=5.63873 μM |
SANGER |
NB12 |
Growth inhibition assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay. IC50=25.2947 μM |
SANGER |
NB10 |
Growth inhibition assay |
|
|
|
Inhibition of human NB10 cell growth in a cell viability assay. IC50=22.2371 μM |
SANGER |
NB13 |
Growth inhibition assay |
|
|
|
Inhibition of human NB13 cell growth in a cell viability assay. IC50=42.6217 μM |
SANGER |
NB5 |
Growth inhibition assay |
|
|
|
Inhibition of human NB5 cell growth in a cell viability assay. IC50=1.41317 μM |
SANGER |
NB14 |
Growth inhibition assay |
|
|
|
Inhibition of human NB14 cell growth in a cell viability assay. IC50=6.43836 μM |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-513 cell growth in a cell viability assay. IC50=4.31217 μM |
SANGER |
NB17 |
Growth inhibition assay |
|
|
|
Inhibition of human NB17 cell growth in a cell viability assay. IC50=31.5185 μM |
SANGER |
NB69 |
Growth inhibition assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay. IC50=1.02945 μM |
SANGER |
NCI-H1048 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1048 cell growth in a cell viability assay. IC50=2.49158 μM |
SANGER |
NBsusSR |
Growth inhibition assay |
|
|
|
Inhibition of human NBsusSR cell growth in a cell viability assay. IC50=3.18254 μM |
SANGER |
LU-135 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-135 cell growth in a cell viability assay. IC50=33.8829 μM |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay. IC50=16.8316 μM |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay. IC50=19.7238 μM |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay. IC50=26.9108 μM |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay. IC50=20.6697 μM |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay. IC50=18.1641 μM |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay. IC50=28.2795 μM |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay. IC50=23.9498 μM |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay. IC50=27.4447 μM |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay. IC50=10.1999 μM |
SANGER |
MLMA |
Growth inhibition assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay. IC50=22.747 μM |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay. IC50=7.28089 μM |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay. IC50=30.8889 μM |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay. IC50=3.87994 μM |
SANGER |
Mo-T |
Growth inhibition assay |
|
|
|
Inhibition of human Mo-T cell growth in a cell viability assay. IC50=18.8204 μM |
SANGER |
NB7 |
Growth inhibition assay |
|
|
|
Inhibition of human NB7 cell growth in a cell viability assay. IC50=2.29676 μM |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay. IC50=6.63171 μM |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay. IC50=34.3889 μM |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay. IC50=50.2744 μM |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay. IC50=58.3648 μM |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay. IC50=56.5819 μM |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
|
Inhibition of human PSN1 cell growth in a cell viability assay. IC50=50.9394 μM |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay. IC50=66.3277 μM |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay. IC50=51.9815 μM |
SANGER |
SK-MEL-30 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay. IC50=133.481 μM |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
|
Inhibition of human SNB75 cell growth in a cell viability assay. IC50=50.414 μM |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay. IC50=70.6017 μM |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay. IC50=50.0201 μM |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay. IC50=52.4982 μM |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay. IC50=51.1085 μM |
SANGER |
A375 |
Growth inhibition assay |
|
|
|
Inhibition of human A375 cell growth in a cell viability assay. IC50=53.6768 μM |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay. IC50=52.9492 μM |
SANGER |
YH-13 |
Growth inhibition assay |
|
|
|
Inhibition of human YH-13 cell growth in a cell viability assay. IC50=60.0468 μM |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay. IC50=76.6063 μM |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay. IC50=60.5077 μM |
SANGER |
ES6 |
Growth inhibition assay |
|
|
|
Inhibition of human ES6 cell growth in a cell viability assay. IC50=57.7541 μM |
SANGER |
D-247MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-247MG cell growth in a cell viability assay. IC50=59.5888 μM |
SANGER |
H4 |
Growth inhibition assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay. IC50=60.5614 μM |
SANGER |
HMV-II |
Growth inhibition assay |
|
|
|
Inhibition of human HMV-II cell growth in a cell viability assay. IC50=157.194 μM |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay. IC50=62.203 μM |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay. IC50=54.091 μM |
SANGER |
K-562 |
Growth inhibition assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay. IC50=50.5633 μM |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay. IC50=56.1737 μM |
SANGER |
M059J |
Growth inhibition assay |
|
|
|
Inhibition of human M059J cell growth in a cell viability assay. IC50=51.0252 μM |
SANGER |
NB6 |
Growth inhibition assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay. IC50=71.0797 μM |
SANGER |
NCI-H1975 |
Proliferation assay |
|
72 h |
|
Antiproliferative activity against human NCI-H1975 cells expressing EGFR T790M mutant after 72 hrs by SRB assay, IC50=0.148 μM |
24183742 |
A431 |
Proliferation assay |
|
72 h |
|
Antiproliferative activity against human A431 cells after 72 hrs by SRB assay, IC50=0.023 nM |
24183742 |
MDA-MB-231 |
Proliferation assay |
|
72 h |
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay, EC50=1 nM |
20180906 |
NCI-H1975 |
Cytotoxicity assay |
|
48 h |
|
Cytotoxicity against human NCI-H1975 cells after 48 hrs by MTT assay, IC50=0.392 μM |
20150404 |
NIH/3T3 |
Cytotoxicity assay |
|
48 h |
|
Cytotoxicity against mouse NIH/3T3 cells after 48 hrs by MTT assay, IC50=3.605 μM |
20150404 |
A549 |
Cytotoxicity assay |
|
72 h |
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay, IC50=0.05 μM |
20180905 |
PC3 |
Cytotoxicity assay |
|
72 h |
|
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay, IC50=4.1 μM |
20180905 |
HeLa |
Cytotoxicity assay |
|
72 h |
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay, IC50=6.81 μM |
20180905 |
MCF7 |
Cytotoxicity assay |
|
72 h |
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay, IC50=5.83 μM |
20180905 |
NSCLC |
Cytotoxicity assay |
|
72 h |
|
Cytotoxicity against human NSCLC cells, IC50=0.5 nM |
20180905 |